Older Adults Face Four Vaccine Decisions This Fall While the Federal Schedule Still Carries a 2025 Date - Medical Daily

Latest News About Osivax and GC Biopharma plan a combined flu vaccine

Osivax and GC Biopharma announced a major partnership to develop a new-generation influenza vaccine. The vaccine aims to combine OVX836 and GC FLU. Osivax gained those rights to advance a combined shot.

Older adults are facing four vaccine decisions this fall, while the federal schedule still carries a 2025 date. Flu and pneumonia deaths have declined for 25 years, but one American age group recorded a rise.

Sources & References